Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Steven Seyedin, MD

Title(s)Assistant Professor, Radiation Oncology
SchoolSchool of Medicine
Address1600 Divisadero, #H1018
San Francisco CA 94115
PronounsHe/Him/His
ORCID ORCID Icon0000-0002-6841-968X Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse awards and honors
    UCSF 2024  - 2025Prostate Cancer Research Pilot Award

    Collapse Overview 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2026 May; 24(5):186-203. Flaig TW, Spiess PE, Abern M, An Y, Bangs R, Begovic J, Brown J, Buyyounouski MK, Chan K, Chang P, Chin AI, Guru KA, Herr HW, Hoffman-Censits J, Kaimakliotis H, Kundu S, Lele SM, Luckenbaugh A, Maldonado J, Mei L, Montgomery JS, Parikh M, Patterson A, Peyton C, Plimack ER, Preston MA, Richards K, Seyedin S, Siefker-Radtke AO, Stewart T, Sundi D, Swami U, Tollefson M, Wright JL, Cassara CJ, Sliker B. PMID: 42140269.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. TIP26-318: Protocol for Wearable AI Tracking to Curb Hospitalizations (WATCH). J Natl Compr Canc Netw. 2026 Mar 31; 24(3.5). Kenny C, Elia M, Fang J, Friesner ID, Liu B, Sears C, Johnson J, Shwan B, Luan H, Ohri N, Braunstein S, Boreta L, Seyedin S, Yoshida E, Chen W, Feng M, Chan J, Hong J. PMID: 41916411.
      View in: PubMed   Mentions:    Fields:    
    3. TIP26-318: Protocol for Wearable AI Tracking to Curb Hospitalizations (WATCH). J Natl Compr Canc Netw. 2026 Mar 31; 24(3.5). Kenny C, Elia M, Feng J, Friesner ID, Liu B, Sears C, Johnson J, Shwan B, Luan H, Ohri N, Braunstein S, Boreta L, Seyedin S, Yoshida E, Chen W, Feng M, Chan J, Hong J. PMID: 41991040.
      View in: PubMed   Mentions:    Fields:    
    4. Addition of pulsed electric field ablation to SBRT for lung tumors: effect on health-related quality of life. Lung Cancer Manag. 2026 Dec; 15(1):2635332. Harris JP, Boyd C, Shi M, Reilly M, Simon A, Seyedin SN, Chen WP, Nagasaka M, Abi-Jaoudeh N, Hoyt MA. PMID: 41783980; PMCID: PMC12969734.
      View in: PubMed   Mentions:
    5. Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder Cancer. Clin Genitourin Cancer. 2026 Feb 21; 24(4):102524. Raizenne BL, Koshkin VS, Zhu A, Ben-David R, Dufault SM, Eraky A, Friedlander TW, Hong JC, Wong AC, Chou J, Chu C, Mar N, Ma TM, Sfakianos JP, Porten S, Seyedin SN. PMID: 41864146.
      View in: PubMed   Mentions:    Fields:    
    6. The association between adherence to elective nodal volume guidelines and reduced distant metastasis in esophageal and gastroesophageal junction cancer: a retrospective analysis of elective nodal irradiation. J Gastrointest Oncol. 2026 Feb 28; 17(1):1. Lyons J, Harada G, Yeakel J, Dayyani F, Smith B, Daly S, Nguyen N, Keshava H, Dufault S, Hui C, Hotca A, Seyedin S. PMID: 41816583; PMCID: PMC12972001.
      View in: PubMed   Mentions:
    7. Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning Approach. Cancer Med. 2025 Dec; 14(23):e71447. Harada GK, Park J, Peterson N, Munjal A, Imagawa D, Jutric Z, Dayyani F, Valerin J, Hong DS, Seyedin SN. PMID: 41347669; PMCID: PMC12679486.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. PrecisionPro Fusion: Clinical validation of an automated, rigid, Prostate-Specific MRI-CT Fusion system for prostate radiotherapy planning. Tech Innov Patient Support Radiat Oncol. 2025 Dec; 36:100353. Do D, Conlin C, Baxter M, Christodouleas J, Dess R, Dragojevic I, Harisinghani M, Kamran S, Moiseenko V, Nagar H, Nakrour N, Nguyen L, Rupareliya R, Seyedin S, Song Y, Dale AM, Seibert TM. PMID: 41322076; PMCID: PMC12661108.
      View in: PubMed   Mentions:
    9. Diagnostic performance of PSMA PET/CT, multiparametric MRI, and combined imaging for local prostate cancer recurrence after radical prostatectomy. Abdom Radiol (NY). 2026 06; 51(6):3010-3021. Phillipi M, Choung D, Ho E, Anavim S, Saeed S, Shu C, Shi J, Glavis-Bloom J, Gupta A, Joshi A, Imanzadeh A, Seyedin S, Uchio E, Daneshvar M, Houshyar R. PMID: 41204951; PMCID: PMC13109148.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Utility of metastasis-directed radiotherapy with and without hormonal therapy in management of oligometastatic prostate cancer. JNCI Cancer Spectr. 2025 Nov 03; 9(6). Chen WS, Tuchayi AM, Sabbagh A, Kim I, Porter E, Ashraf-Ganjouei A, Li YR, Witztum A, Rajagopal A, Seyedin SN, Juarez R, Carroll PR, Feng FY, Small EJ, Hope TA, Hong JC. PMID: 41063390; PMCID: PMC12582589.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Pilot Study of Combining Stereotactic Body Radiation Therapy with Pulsed Field Ablation for Oligometastatic/Oligoprogressive Lung Tumors. J Vasc Interv Radiol. 2025 11; 36(11):1687-1695. Harris JP, Boyd C, Shi M, Reilly M, Simon A, Seyedin SN, Chen WP, Nagasaka M, Nabar R, Abi-Jaoudeh N. PMID: 40803526; PMCID: PMC12582577.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    12. Observation of acute toxicity events in lung cancer patients treated concurrently with a tyrosine kinase inhibitor. Cancer Treat Res Commun. 2025; 44:100947. Harada GK, Ku E, Munjal A, Yeakel J, Juma S, Maxim P, Seyedin S, Nagasaka M, Chen A, Harris J. PMID: 40440753.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. A Predictive Nomogram for Development of Lymph Node Metastasis in Muscle-Invasive Bladder Cancer Following Neoadjuvant Therapy. Adv Radiat Oncol. 2025 Jan; 10(1):101671. Harada GK, Seyedin SN, Heutlinger O, Azizi A, Hsu A, Rezazadeh A, Daneshvar M, Gin GE, Uchio EM, Giannico GA, Harris JP, Simon AB, Kuo JV, Mar N. PMID: 39655154; PMCID: PMC11626798.
      View in: PubMed   Mentions: 1  
    14. Safety Analysis of Co-Administration of Radiation Therapy with Enfortumab Vedotin Based Regimens in Metastatic Urothelial Carcinoma. Clin Genitourin Cancer. 2024 Dec; 22(6):102243. Seyedin SN, Harada GK, Garemanian E, Rafizadeh D, Kaakour D, Dwabe S, Rezazadeh A, Daneshvar M, Mar N. PMID: 39520850.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Socioeconomic Barriers to Receiving Early Salvage Radiotherapy for Locally Advanced Prostate Adenocarcinoma: A Retrospective Single-Center Study. Cureus. 2024 Sep; 16(9):e68945. Heutlinger O, Azizi A, Harada G, Harris JP, Daneshvar M, Gin G, Uchio E, Mar N, Rezazadeh A, Seyedin SN. PMID: 39381448; PMCID: PMC11460723.
      View in: PubMed   Mentions:
    16. Use of Radiation Therapy for Ataxia-Telangiectasia Mutated (ATM)-Mutation Metastatic Renal Cell Carcinoma: A Case Report. Cureus. 2024 Jul; 16(7):e64781. Seyedin SN, Harada G, Garemanian E, Rafizadeh D, Kaakour D, Dwabe S, Daneshvar M, Mar N. PMID: 39156348; PMCID: PMC11329860.
      View in: PubMed   Mentions:
    17. The Impact of Local Control on Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Cancer: A Retrospective Analysis. Cancers (Basel). 2024 Jun 29; 16(13). Yeakel J, Seyedin SN, Harada G, Hagopian G, Mahmood S, Bennett R, Harris JP, Abbott EM, Lindner S, Dayyani F, Sehgal V, Kuo JV, Abi-Jaoudeh N. PMID: 39001464; PMCID: PMC11240767.
      View in: PubMed   Mentions: 1  
    18. Integrating Overall Survival and Tumor Control Probability Models to Predict Local Progression After Brain Metastasis Radiosurgery. Adv Radiat Oncol. 2024 Jun; 9(6):101474. Simon AB, Quezada J, Mohyeldin A, Harris J, Shi M, Seyedin S, Sehgal V, Chen AM. PMID: 38681893; PMCID: PMC11043807.
      View in: PubMed   Mentions:
    19. A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma. Cancer Control. 2024 Jan-Dec; 31:10732748241237331. Harris JP, Park J, Ku E, Seyedin S, Stitzlein R, Goldin A, Chen WP, McLaren C, Chen AM, Chow W. PMID: 38449377; PMCID: PMC10919132.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    20. Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC). Clin Genitourin Cancer. 2024 04; 22(2):217-223. Mar N, Dwabe S, Baranda MN, Zarrabi KK, Eturi A, Gulati S, Parikh M, Seyedin SN, Kalebasty AR. PMID: 38087703.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. The Correlation Between Lymphocyte Nadir and Radiation Therapy for Soft Tissue Sarcoma: Defining Key Dosimetric Parameters and Outlining Clinical Significance. Adv Radiat Oncol. 2024 Jan; 9(1):101309. Ku E, Harada G, Chiao E, Rao P, Hosseinian S, Seyedin S, Healy E, Maxim P, Chow W, Stitzlein R, Limoli C, Harris J. PMID: 38260229; PMCID: PMC10801664.
      View in: PubMed   Mentions: 1  
    22. Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients. Biosens Bioelectron. 2023 Apr 15; 226:115117. Poellmann MJ, Bu J, Liu S, Wang AZ, Seyedin SN, Chandrasekharan C, Hong H, Kim Y, Caster JM, Hong S. PMID: 36753988; PMCID: PMC10034717.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    23. Combination of Pembrolizumab and Stereotactic Body Radiation Therapy in Recurrent Metastatic Penile Squamous Cell Carcinoma: A Case Study. Biomedicines. 2022 Nov 24; 10(12). Kaakour D, Seyedin S, Houshyar R, Mar N. PMID: 36551787; PMCID: PMC9775235.
      View in: PubMed   Mentions: 2  
    24. The potential of biology-guided radiation therapy in thoracic cancer: A preliminary treatment planning study. Front Oncol. 2022; 12:921473. Seyedin SN, Bassalow R, Mawlawi OR, Turner LM, Patel RR, Mazin SR, Oderinde OM, Voronenko Y, Wages CA, Olcott PD, Chang JY, Balter PA, Welsh JW. PMID: 36313653; PMCID: PMC9613936.
      View in: PubMed   Mentions: 4  
    25. A phase Ib feasibility trial of response adapted neoadjuvant therapy in gastric cancer (RANT-GC). Future Oncol. 2022 Jul; 18(21):2615-2622. Dayyani F, Smith BR, Nguyen NT, Daly S, Hinojosa MW, Seyedin SN, Kuo J, Samarasena JB, Lee JG, Taylor TH, Cho MT, Senthil M. PMID: 35603628; PMCID: PMC9437768.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Controversies in Lung Cancer: Heterogeneity in Treatment Recommendations for Stage III NSCLC According to Disease Burden and Oncogenic Driver Alterations. Clin Lung Cancer. 2022 06; 23(4):333-344. Harris JP, Fujimoto DK, Nagasaka M, Ku E, Harada G, Keshava H, Mahtabifard A, Longoria J, Patel N, Seyedin S, Simon A, Chen A. PMID: 35256282.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation Therapy. Adv Radiat Oncol. 2021 Nov-Dec; 6(6):100778. Seyedin SN, Watkins JM, Mayo Z, Snow AN, Laszewski M, Russo JK, Mott SL, Tracy CR, Smith MC, Buatti JM, Caster JM. PMID: 34934861; PMCID: PMC8655410.
      View in: PubMed   Mentions: 2  
    28. The Role of Definitive Radiation and Surgery in Metastatic Esophageal Cancer: An NCDB Investigation. Ann Thorac Surg. 2021 08; 112(2):459-466. Seyedin SN, Parekh KR, Ginader T, Caster JM. PMID: 33096068.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    29. The Effect of Concurrent Stereotactic Body Radiation and Anti-PD-1 Therapy for Recurrent Metastatic Sarcoma. Radiat Res. 2020 08 01; 194(2):124-132. Callaghan CM, Seyedin SN, Mohiuddin IH, Hawkes KL, Petronek MS, Anderson CM, Buatti JM, Milhem MM, Monga V, Allen BG. PMID: 32845986; PMCID: PMC10443123.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    30. Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma. Front Oncol. 2020; 10:1311. Seyedin SN, Gannon MK, Plichta KA, Abushahin L, Berg DJ, Arshava EV, Parekh KR, Keech JC, Caster JM, Welsh JW, Allen BG. PMID: 32850412; PMCID: PMC7412633.
      View in: PubMed   Mentions: 3  
    31. Local management of preinvasive and clinical T1-3 penile cancer: utilization of diverse treatment modalities. Future Oncol. 2020 May; 16(14):955-960. Menon H, Patel RR, Ludmir EB, Muralidhar V, Cushman TR, Amini A, Seyedin SN, Nguyen PL, Verma V. PMID: 32301342.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    32. Management and outcomes of primary anorectal melanoma in the United States. Future Oncol. 2020 Mar; 16(8):329-338. Menon H, Patel RR, Cushman TR, Amini A, Seyedin SN, Adams AC, Lin C, Verma V. PMID: 32067486.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    33. Combination Therapy with Radiation and PARP Inhibition Enhances Responsiveness to Anti-PD-1 Therapy in Colorectal Tumor Models. Int J Radiat Oncol Biol Phys. 2020 09 01; 108(1):81-92. Seyedin SN, Hasibuzzaman MM, Pham V, Petronek MS, Callaghan C, Kalen AL, Mapuskar KA, Mott SL, Spitz DR, Allen BG, Caster JM. PMID: 32036006; PMCID: PMC7416439.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    34. Deep segmentation networks predict survival of non-small cell lung cancer. Sci Rep. 2019 11 21; 9(1):17286. Baek S, He Y, Allen BG, Buatti JM, Smith BJ, Tong L, Sun Z, Wu J, Diehn M, Loo BW, Plichta KA, Seyedin SN, Gannon M, Cabel KR, Kim Y, Wu X. PMID: 31754135; PMCID: PMC6872742.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    35. Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol. 2019 11 01; 5(11):1597-1604. Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW. PMID: 31529018; PMCID: PMC6749545.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    36. First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma. Clin Cancer Res. 2019 11 15; 25(22):6590-6597. Allen BG, Bodeker KL, Smith MC, Monga V, Sandhu S, Hohl R, Carlisle T, Brown H, Hollenbeck N, Vollstedt S, Greenlee JD, Howard MA, Mapuskar KA, Seyedin SN, Caster JM, Jones KA, Cullen JJ, Berg D, Wagner BA, Buettner GR, TenNapel MJ, Smith BJ, Spitz DR, Buatti JM. PMID: 31427282; PMCID: PMC6858950.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    37. Optimizing Advances in Nanoparticle Delivery for Cancer Immunotherapy. Adv Drug Deliv Rev. 2019 04; 144:3-15. Caster JM, Callaghan C, Seyedin SN, Henderson K, Sun B, Wang AZ. PMID: 31330165; PMCID: PMC11849717.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    38. Clinical Utility of Pretreatment and 3-Month 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Standardized Uptake Value in Predicting and Assessing Recurrence in T3-T4 Laryngeal Carcinoma Treated With Definitive Radiation. Ann Otol Rhinol Laryngol. 2019 Jul; 128(7):595-600. Mayo Z, Seyedin SN, Mallak N, Mott SL, Menda Y, Graham M, Anderson C. PMID: 30808209.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Cutaneous malignant melanoma of the oral cavity following skin graft reconstruction: Case report. Head Neck. 2019 02; 41(2):E26-E29. Mayo Z, Seyedin S, Marquardt M, Mohiuddin I, Milhem M, Liu V, Pagedar N, Anderson C. PMID: 30537068.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone. Pathol Oncol Res. 2019 Jan; 25(1):209-215. Seyedin SN, Mitchell DL, Mott SL, Russo JK, Tracy CR, Snow AN, Parkhurst JR, Smith MC, Buatti JM, Watkins JM. PMID: 29079967; PMCID: PMC5924586.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation. Transl Lung Cancer Res. 2017 Apr; 6(2):148-158. Schoenhals JE, Seyedin SN, Anderson C, Brooks ED, Li YR, Younes AI, Niknam S, Li A, Barsoumian HB, Cortez MA, Welsh JW. PMID: 28529897; PMCID: PMC5420535.
      View in: PubMed   Mentions: 22  
    42. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. J Thorac Oncol. 2017 02; 12(2):375-382. Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RU. PMID: 27794500.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    43. Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local Control. Cancer J. 2016 Mar-Apr; 22(2):130-7. Schoenhals JE, Seyedin SN, Tang C, Cortez MA, Niknam S, Tsouko E, Chang JY, Hahn SM, Welsh JW. PMID: 27111909.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    44. Strategies for combining immunotherapy with radiation for anticancer therapy. Immunotherapy. 2015; 7(9):967-980. Seyedin SN, Schoenhals JE, Lee DA, Cortez MA, Wang X, Niknam S, Tang C, Hong DS, Naing A, Sharma P, Allison JP, Chang JY, Gomez DR, Heymach JV, Komaki RU, Cooper LJ, Welsh JW. PMID: 26310908; PMCID: PMC4825325.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    45. Author's view: radiation and immunotherapy as systemic therapy for solid tumors. Oncoimmunology. 2015 Jan; 4(3):e986402. Seyedin SN, Tang C, Welsh JW. PMID: 25949899; PMCID: PMC4404906.
      View in: PubMed   Mentions: 6     Fields:    
    46. Galectin-1 and immune suppression during radiotherapy. Clin Cancer Res. 2014 Dec 15; 20(24):6230-2. Welsh JW, Seyedin SN, Cortez MA, Maity A, Hahn SM. PMID: 25348514.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    47. Combining radiation and immunotherapy: a new systemic therapy for solid tumors? Cancer Immunol Res. 2014 Sep; 2(9):831-8. Tang C, Wang X, Soh H, Seyedin S, Cortez MA, Krishnan S, Massarelli E, Hong D, Naing A, Diab A, Gomez D, Ye H, Heymach J, Komaki R, Allison JP, Sharma P, Welsh JW. PMID: 25187273; PMCID: PMC5367158.
      View in: PubMed   Mentions: 182     Fields:    Translation:HumansAnimals
    48. Effect of socioeconomic status on surgery for pancreatic adenocarcinoma. Am Surg. 2012 Oct; 78(10):1128-31. Seyedin S, Luu C, Stabile BE, Lee B. PMID: 23025956.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    49. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways. PLoS One. 2010 Dec 30; 5(12):e15805. Wang J, Taherbhoy AM, Hunt HW, Seyedin SN, Miller DW, Miller DJ, Huang DT, Schulman BA. PMID: 21209884; PMCID: PMC3012696.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    50. Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. Mol Cell. 2009 Oct 09; 36(1):39-50. Zhuang M, Calabrese MF, Liu J, Waddell MB, Nourse A, Hammel M, Miller DJ, Walden H, Duda DM, Seyedin SN, Hoggard T, Harper JW, White KP, Schulman BA. PMID: 19818708; PMCID: PMC2847577.
      View in: PubMed   Mentions: 296     Fields:    Translation:HumansAnimalsCells
    51. The mechanism of ATP-dependent primer-template recognition by a clamp loader complex. Cell. 2009 May 15; 137(4):659-71. Simonetta KR, Kazmirski SL, Goedken ER, Cantor AJ, Kelch BA, McNally R, Seyedin SN, Makino DL, O'Donnell M, Kuriyan J. PMID: 19450514; PMCID: PMC2684988.
      View in: PubMed   Mentions: 91     Fields:    Translation:Cells
    Steven's Networks
    Concepts (189)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (59)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-22-g09c84f92 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.